Rituximab-Induced Hypogammaglobulinemia and Risk of Infection in Neuromyelitis Optica Spectrum Disorders

Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study

(2021) Stefanie D. Wade et al.   RHEUMATOLOGY INTERNATIONAL

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease

(2021) Joanna Tieu et al.   Frontiers in Immunology

Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody–Associated Diseases

(2021) Alexandre Avouac et al.   Neurology-Neuroimmunology & Neuroinflammation

Anti-CD20 antibody therapy and risk of infection in patients with demyelinating diseases

(2021) N.R. Oksbjerg et al.   Multiple Sclerosis and Related Disorders

Serious safety events in rituximab‐treated multiple sclerosis and related disorders

(2020) Brandi L. Vollmer et al.   Annals of Clinical and Translational Neurology

Obesity Accelerates Age Defects in Mouse and Human B Cells

(2020) Daniela Frasca et al.   Frontiers in Immunology

Predicting severe infection and effects of hypogammaglobulinaemia during therapy with rituximab in rheumatic and musculoskeletal diseases

(2019) Md Yuzaiful Md Yusof et al.   Arthritis & Rheumatology

Prolonged Impairment of Immunological Memory After Anti-CD20 Treatment in Pediatric Idiopathic Nephrotic Syndrome

(2019) Manuela Colucci et al.   Frontiers in Immunology

Consequences of B-cell-depleting therapy: hypogammaglobulinemia and impaired B-cell reconstitution

(2018) Keith A Sacco et al.   Immunotherapy

Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation

(2018) E. C. Tallantyre et al.   JOURNAL OF NEUROLOGY

Less frequent rituximab retreatment maintains remission of neuromyelitis optica spectrum disorder, following long-term rituximab treatment

(2018) Su-Hyun Kim et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Predictors of hypogammaglobulinemia during rituximab maintenance therapy in rheumatoid arthritis: A 12-year longitudinal multi-center study

(2018) G. Boleto et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis

(2018) Tamara H Ramwadhdoebe et al.   RHEUMATOLOGY

Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease

(2015) Darren M. Roberts et al.   JOURNAL OF AUTOIMMUNITY

Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: A case series

(2015) Darren M. Roberts et al.   JOURNAL OF AUTOIMMUNITY

Longterm Safety of Rituximab: Final Report of the Rheumatoid Arthritis Global Clinical Trial Program over 11 Years

(2015) R. F. van Vollenhoven et al.   JOURNAL OF RHEUMATOLOGY

Treatment Outcomes With Rituximab in 100 Patients With Neuromyelitis Optica

(2015) Su-Hyun Kim et al.   JAMA Neurology

The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease

(2014) Helena Marco et al.   BMC MUSCULOSKELETAL DISORDERS

Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia

(2012) Francesco Zaja et al.   AMERICAN JOURNAL OF HEMATOLOGY

B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells

(2012) Matthieu Mahévas et al.   JOURNAL OF CLINICAL INVESTIGATION

Total serum immunoglobulin levels in patients with RA after multiple B-cell depletion cycles based on rituximab: relationship with B-cell kinetics

(2012) Inmaculada De La Torre et al.   RHEUMATOLOGY

Repeated Treatment With Rituximab Based on the Assessment of Peripheral Circulating Memory B Cells in Patients With Relapsing Neuromyelitis Optica Over 2 Years

(2011) Su-Hyun Kim   ARCHIVES OF NEUROLOGY

Connecting obesity, aging and diabetes

(2009) Rexford S. Ahima   NATURE MEDICINE

Serum Immunoglobulins and Risk of Infection: How Low Can You Go?

(2008) Daniel E. Furst   SEMINARS IN ARTHRITIS AND RHEUMATISM